Reference | </br>1:Toxicity and anti-angiogenicity evaluation of Pak1 inhibitor IPA-3 using zebrafish embryo model. Jagadeeshan S, Sagayaraj RV, Paneerselvan N, Ghouse SS, Malathi R.Cell Biol Toxicol. 2017 Feb;33(1):41-56. doi: 10.1007/s10565-016-9358-5. Epub 2016 Aug 31. PMID: 27581547 </br>2:Liposome-mediated delivery of the p21 activated kinase-1 (PAK-1) inhibitor IPA-3 limits prostate tumor growth in vivo. Al-Azayzih A, Missaoui WN, Cummings BS, Somanath PR.Nanomedicine. 2016 Jul;12(5):1231-9. doi: 10.1016/j.nano.2016.01.003. Epub 2016 Mar 3. PMID: 26949163 </br>3:Inhibition of p21-Activated Kinase 1 by IPA-3 Promotes Locomotor Recovery After Spinal Cord Injury in Mice. Ji X, Zhang Y, Zhang L, Chen H, Peng Y, Tang P.Spine (Phila Pa 1976). 2016 Jun;41(11):919-25. doi: 10.1097/BRS.0000000000001491. PMID: 26863260 </br>4:Inhibition of p21-activated kinase 1 by IPA-3 attenuates secondary injury after traumatic brain injury in mice. Ji X, Zhang W, Zhang L, Zhang L, Zhang Y, Tang P.Brain Res. 2014 Oct 17;1585:13-22. doi: 10.1016/j.brainres.2014.08.026. Epub 2014 Aug 20. PMID: 25148711 </br>5:Group I PAK inhibitor IPA-3 induces cell death and affects cell adhesivity to fibronectin in human hematopoietic cells. Kuželová K, Grebeňová D, Holoubek A, Röselová P, Obr A.PLoS One. 2014 Mar 24;9(3):e92560. doi: 10.1371/journal.pone.0092560. eCollection 2014. PMID: 24664099 Free PMC Article</br>6:IPA-3 inhibits the growth of liver cancer cells by suppressing PAK1 and NF-κB activation. Wong LL, Lam IP, Wong TY, Lai WL, Liu HF, Yeung LL, Ching YP.PLoS One. 2013 Jul 19;8(7):e68843. doi: 10.1371/journal.pone.0068843. Print 2013. PMID: 23894351 Free PMC Article
|